证券代码：301076 证券简称：新瀚新材 公告编号：2025-049 江苏新瀚新材料股份有限公司 关于控股股东、实际控制人减持股份触及 1%整倍数的公告 近日，公司收到控股股东及实际控制人秦翠娥女士出具的《股份减持实施进展 告知函》，获悉秦翠娥女士于2025年10月31日通过集中竞价方式减持所持有公司股 份90,000股，占公司总股本的0.05% 。本次权益变动后，秦翠娥女士持有公司股份 33,963,500股，持股比例由 19.47%变动为19.42% ；秦翠娥女士及一致行动人严留新 先生合计持有公司股份 73,404,044股，持股比例由42.03%变动为 41.97% ，本次权 益变动触及 1%整倍数。现将有关情况公告如下： | 1．基本情况 | | | --- | --- | | 信息披露义务人 | 秦翠娥 | | 住所 | 江苏省南京市*** | | 权益变动时间 | 2025年 10月 31 日 | | 权益变动过程 | 控股股东及实际控制人秦翠娥女士因个人资金需求， 在2025年10月31日通过集中竞价方式减持公司股份90,000 | | | 股，个人持股比例由 19.47%减少至 19.42 ...

Core Viewpoint - Xinhan New Materials is a leading company in the aromatic ketone products sector, with significant technological and industrial chain advantages, focusing on specialty plastic core materials, photoinitiators, and cosmetic raw materials [1] Business Performance - In Q3 2025, Xinhan New Materials achieved revenue of 330 million yuan, ranking 69th among 79 companies in the industry, significantly lower than the top company, Sinochem International, which reported 35.716 billion yuan [2] - The main business composition includes specialty engineering plastic core materials at 97.028 million yuan (42.36%), cosmetic raw materials at 47.2895 million yuan (20.64%), intermediates and others at 46.3864 million yuan (20.25%), and photoinitiators at 38.3639 million yuan (16.75%) [2] - The net profit for the same period was 51.5261 million yuan, ranking 42nd in the industry, also below the industry average of 74.4382 million yuan [2] Financial Health - As of Q3 2025, the company's debt-to-asset ratio was 7.92%, lower than the previous year's 8.47% and significantly below the industry average of 34.74%, indicating strong solvency [3] - The gross profit margin for the period was 27.52%, up from 24.61% year-on-year and higher than the industry average of 19.93%, reflecting robust profitability [3] Management and Shareholder Information - The chairman, Yan Liuxin, received a salary of 962,000 yuan in 2024, an increase of 47,000 yuan from 2023 [4] - As of September 30, 2025, the number of A-share shareholders decreased by 7.23% to 30,700, while the average number of circulating A-shares held per shareholder increased by 7.78% to 3,575.75 [5] Market Position and Growth Prospects - The company is recognized as a leader in aromatic ketone products based on the Fuchs reaction, with notable advantages in technology and industrial chain [5] - Key highlights include the broad demand for fluoroketone as a PEEK raw material, stable end customers for photoinitiators, and a booming high-end market for cosmetic raw materials [5] - The company is expanding production capacity, with expected net profits of 79 million yuan, 85 million yuan, and 100 million yuan for 2025, 2026, and 2027 respectively, translating to EPS of 0.45, 0.49, and 0.57 yuan per share [5][6]

Market Overview - The chemical products sector experienced a decline of 0.57% on the trading day, with Boyuan Co., Ltd. leading the losses [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the chemical products sector included: - Hangzhou Oxygen Plant Co., Ltd. (002430) with a closing price of 29.52, up 9.99% and a trading volume of 494,700 shares, totaling 1.43 billion yuan [1] - Pioneer New Materials (300163) closed at 4.93, up 6.94% with a trading volume of 1,542,200 shares, totaling 759 million yuan [1] - Jinrongzi (002407) closed at 26.50, up 6.26% with a trading volume of 2,445,100 shares, totaling 6.408 billion yuan [1] - Major decliners included: - Boyuan Co., Ltd. (301617) closed at 94.00, down 7.66% with a trading volume of 78,600 shares, totaling 763 million yuan [2] - Jinhua New Materials (920015) closed at 58.33, down 7.29% with a trading volume of 132,100 shares, totaling 810 million yuan [2] - Poly United (002037) closed at 10.10, down 6.13% with a trading volume of 247,400 shares, totaling 254 million yuan [2] Capital Flow - The chemical products sector saw a net outflow of 933 million yuan from institutional investors, while retail investors contributed a net inflow of 665 million yuan [2] - The capital flow for specific stocks indicated: - Hangzhou Oxygen Plant Co., Ltd. had a net inflow of 1.52 billion yuan from institutional investors, while retail investors had a net outflow of 948.96 million yuan [3] - Yongtai Technology (002326) experienced a net inflow of 1.25 billion yuan from institutional investors, with a net outflow of 2.22 billion yuan from retail investors [3] - Yahua Group (002497) had a net inflow of 1.08 billion yuan from institutional investors, while retail investors saw a net outflow of 657.87 million yuan [3]

Group 1 - The robotics sector experienced significant fluctuations, with notable gains in several companies [1] - Nanjing Julong saw an increase of over 12% [1] - Yongmaotai previously hit the daily limit up, while Qingdao Double Star achieved three consecutive trading limits [1] Group 2 - Other companies such as Dayang Electric, Sanhua Intelligent Control, and Xinhang New Materials also showed upward trends [1]

证券代码：301076 证券简称：新瀚新材 公告编号：2025-048 江苏新瀚新材料股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 统一社会信用代码：91320000678952216F 类 型：股份有限公司（上市） 住 所：南京化学工业园区崇福路51号 法定代表人：严留新 注册资本：17488.12万元整 成立日期：2008年07月25日 1 江苏新瀚新材料股份有限公司（以下简称"公司"）分别于2025年8月25日、 2025年9月16日召开第四届董事会第五次会议和2025年第一次临时股东大会，审议 通过了《关于修订<公司章程>的议案》，并授权公司管理层具体办理本次工商变 更登记及章程备案事宜。具体内容详见公司于2025年8月26日在巨潮资讯网 （www.cninfo.com.cn）上披露的《关于修订《公司章程》及相关制度的公告》 （公告编号：2025-034）。 近日，公司完成了注册资本事项的工商变更登记手续及《江苏新瀚新材料股 份有限公司章程》备案手续，并取得了南京市市场监督管理局换发的《营业执 照 ...

Summary of Newhan New Materials Q3 2025 Conference Call Company Overview - **Company**: Newhan New Materials - **Industry**: Chemical Materials, specifically focusing on Pico products, photoinitiators, cosmetic raw materials, and pharmaceutical/agricultural intermediates Key Financial Metrics - **Pico Core Monomer**: Revenue contribution over 40%, with a shipment volume of approximately 1,600 tons and a gross margin of about 32% [2][3] - **Photoinitiators**: Revenue close to 60 million, accounting for about 15% of total revenue, with sales exceeding 1,500 tons [2][3] - **Cosmetic Raw Materials**: Revenue around 73 million, shipment volume of 1,300 tons, and a gross margin near 10% [2][3] - **Pharmaceutical/Agricultural Intermediates**: Revenue between 50 to 60 million, with a shipment volume of around 1,200 tons and a gross margin close to 40% [2][3] Business Performance Insights - **Overall Performance**: Significant growth in net profit exceeding revenue growth, with a gross margin of 27.52% for the first three quarters [3] - **Cosmetic Raw Materials**: Decline in gross margin attributed to proactive price reductions to capture market share and high fixed costs due to longer production times [2][5] - **DLBP Product**: New plant designed for a capacity of 2,500 tons, meeting 2025 demand with nearly 1,600 tons sold in the first three quarters [2][6] Market Dynamics - **Pico Product Demand**: Anticipated growth in downstream demand for Pico products, with a sales growth rate of 30% driven by price reductions [4][11] - **Cosmetic Products**: Market performance is strong, with a projected 20%-30% increase in shipments compared to 2024 [15][16] - **DLBP Pricing Pressure**: Current DLBP price around 90,000 yuan/ton, with competitive pressures from new production lines but maintained gross margins due to cost reductions and efficiency improvements [9][8] Strategic Initiatives - **Supply Strategy Adjustments**: Shift to sourcing from Indian production to mitigate impacts from US-China tariffs, ensuring business stability [4][19] - **Incentive Mechanism Changes**: Adjustments aimed at quickly increasing production capacity utilization while maintaining reasonable gross margins [20] - **Focus on Comprehensive Solutions**: Commitment to becoming a comprehensive solution provider in the Pico industry chain, with ongoing development in leather applications [13] Industry Standards and Challenges - **Industry Standards**: Company relies on internal standards developed over two decades due to technical confidentiality, rather than participating in broader industry standardization [14] - **Upstream Supply Chain Barriers**: Recognition of barriers in the upstream supply chain, with a focus on maintaining quality and cost advantages [23] Future Outlook - **Q4 Sales Projections**: Anticipated growth rate of 30% for Q4, with no significant increases in raw material prices expected [26] - **Capacity Planning**: Peak capacity could exceed 3,000 tons if all production lines are utilized, with potential to meet 5,000 tons of orders in 2026 [21][22] Additional Considerations - **Depreciation Impact**: Past significant depreciation costs have stabilized, with current monthly depreciation around 200-300 thousand yuan [24] - **Special Engineering Plastics Project**: Currently in design and verification stages, with a cautious approach to ensure product quality and pricing advantages [25]

Group 1 - The company Xinhan New Materials announced that it will hold an investor research meeting on October 21, 2025, from 10:00 to 10:40, with participation from the company's board secretary, Li Xiangfei, and other representatives to address investor inquiries [1] Group 2 - The article emphasizes the need to shift funding focus from excessive investment in housing and infrastructure to enhancing investments in the livelihood sector [1]

Financial Performance - In the first three quarters of 2025, the company achieved a revenue of 330 million CNY, representing a year-on-year growth of 7.99% [2] - The net profit for the same period was 51.53 million CNY, showing a year-on-year increase of 23.32% [2] Product Sales Composition - The sales composition of the company's main products includes: - DFBP: 40% - Photoinitiators: 18% - Cosmetic raw materials: 22% - Agricultural and pharmaceutical intermediates: approximately 20% [3] Product Pricing and Capacity - The pricing of DFBP is influenced by raw material costs and is currently at a low level due to these factors; however, production capacity is increasing, leading to gradual recovery in gross margins [4] - The demand for PEEK is growing due to its excellent properties, with applications in aerospace, medical implants, and high-end manufacturing, indicating a positive industry outlook [5] - The production and market expansion of HAP are progressing normally, with sales growth attributed to new customer acquisition and increased penetration [6] Investment Projects - The progress of the fundraising project for the third workshop (HDO) is ongoing, with equipment installation expected to be completed by December 2025 [7] Margin Improvement Factors - The recovery in product gross margins is primarily due to stable increases in capacity utilization, reduced fixed costs per unit, and a decrease in raw material prices during the first three quarters of 2025 [8]

Core Viewpoint - New Hanxin Materials (301076.SZ) reported a revenue of 330 million yuan for the first three quarters, reflecting a year-on-year growth of 7.99% [1] - The net profit attributable to shareholders reached 51.526 million yuan, marking a year-on-year increase of 23.32% [1] - The net profit after deducting non-recurring gains and losses was 42.4 million yuan, showing an 18.05% year-on-year growth [1] Financial Performance - Revenue for the first three quarters: 330 million yuan, up 7.99% year-on-year [1] - Net profit attributable to shareholders: 51.526 million yuan, up 23.32% year-on-year [1] - Net profit after deducting non-recurring gains: 42.4 million yuan, up 18.05% year-on-year [1]

证券代码：301076 证券简称：新瀚新材 公告编号：2025-047 江苏新瀚新材料股份有限公司 第四届董事会第七次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，无虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 江苏新瀚新材料股份有限公司（以下简称"公司"）于2025年10月20日在公司 会议室以现场会议与电话视频会议相结合的方式召开了第四届董事会第七次会议。 会议通知已于2025年10月15日以电话和邮件的方式送达全体董事。会议应到董事9 人，实到董事9人，其中以通讯方式出席1人，为李国伟先生。公司高级管理人员列 席了本次会议。会议由董事长严留新先生召集并主持。本次会议的召开及表决程序 符合《公司法》及《公司章程》的有关规定。 二、董事会会议审议情况 经与会董事审议表决，形成如下决议： 1、以9票同意、0票反对、0票弃权，审议通过《关于<2025年第三季度报告>的 议案》； 经审议，董事会认为公司《2025年第三季度报告》编制和审议程序符合法律、 行政法规及中国证监会的规定，报告内容真实、准确、完整地反映了公司2025年第 三季度的经营管理情况，不存在任何虚假记载、误导性陈 ...